{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "drug repurposing",
      "therapeutics",
      "vaccines"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "2019\u5e7412\u6708\u306b\u4e2d\u56fd\u30fb\u6b66\u6f22\u3067\u3001\u65b0\u578b\u91cd\u75c7\u6025\u6027\u547c\u5438\u5668\u75c7\u5019\u7fa4\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b92\uff08severe acute respiratory syndrome coronavirus 2\uff1aSARS-CoV-2\uff09\u306e\u611f\u67d3\u75c7\u306b\u8d77\u56e0\u3059\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff08coronavirus disease 2019\uff1aCOVID-19\uff09\u306e\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u304c\u767a\u751f\u3057\u305f\u3002\u3053\u306e\u65b0\u578b\u30a6\u30a4\u30eb\u30b9\u306f\u3001\u30a8\u30f3\u30d9\u30ed\u30fc\u30d7\u578bRNA\u30d9\u30fc\u30bf\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u5c5e\u306b\u5206\u985e\u3055\u308c\u308b\u3002\u75c7\u72b6\u306f\u611f\u67d3\u8005\u3054\u3068\u306b\u7570\u306a\u308b\u304c\u3001\u4e3b\u3068\u3057\u3066\u7a7a\u54b3\u3001\u9f3b\u9589\u3001\u606f\u5207\u308c\u3001\u767a\u71b1\u3001\u5168\u8eab\u5026\u6020\u306a\u3069\u3092\u5448\u3059\u308b\u3002\u3053\u306e\u75be\u60a3\u306f\u3001\u60a3\u8005\u304c60\u6b73\u3092\u904e\u304e\u3066\u3044\u308b\u5834\u5408\u3084\u3001\u7cd6\u5c3f\u75c5\u3001\u764c\u3001\u5fc3\u8840\u7ba1\u75be\u60a3\u3001\u6162\u6027\u547c\u5438\u5668\u75c5\u3001\u9ad8\u8840\u5727\u306a\u3069\u306e\u57fa\u790e\u75be\u60a3\u3092\u6709\u3059\u308b\u5834\u5408\u306b\u91cd\u75c7\u5ea6\u304c\u9ad8\u304f\u306a\u308b\u3068\u307f\u3089\u308c\u3066\u3044\u308b\u3002\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306b\u5bfe\u3059\u308b\u30ef\u30af\u30c1\u30f3\u306f\u4f9d\u7136\u3068\u3057\u3066\u3044\u305a\u308c\u3082\u672a\u627f\u8a8d\u3067\u3042\u308b\u304c\u3001\u73fe\u5728100\u7a2e\u3092\u8d85\u3048\u308b\u30ef\u30af\u30c1\u30f3\u304c\u3055\u307e\u3056\u307e\u306a\u958b\u767a\u6bb5\u968e\u306b\u3042\u308b\u3002\u65b0\u85ac\u306e\u958b\u767a\u306f\u76f8\u5bfe\u7684\u306b\u9577\u6642\u9593\u3092\u8981\u3059\u308b\u3053\u3068\u304c\u77e5\u3089\u308c\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u3001\u3059\u3067\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u65e2\u77e5\u306e\u8907\u6570\u306e\u85ac\u5264\u304c\u3053\u306e\u75be\u60a3\u306e\u6cbb\u7642\u76ee\u7684\u3067\u5229\u7528\u3055\u308c\u3066\u3044\u308b\u3002\u672c\u7a3f\u3067\u306f\u3001\u3053\u306e\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u304b\u30896\u30f5\u6708\u3092\u7d4c\u305f\u73fe\u6642\u70b9\u3067COVID-19\u306b\u5229\u7528\u3067\u304d\u308b\u6cbb\u7642\u6cd5\u3068\u30ef\u30af\u30c1\u30f3\u306e\u9078\u629e\u80a2\u3092\u691c\u8a0e\u3059\u308b\u3002\u6cbb\u7642\u9078\u629e\u80a2\u306e\u4e2d\u3067\u6700\u3082\u6ce8\u76ee\u306b\u5024\u3059\u308b\u3082\u306e\u306f\u3001\u30c7\u30ad\u30b5\u30e1\u30bf\u30be\u30f3\u3001\u30ec\u30e0\u30c7\u30b7\u30d3\u30eb\u3001\u30a2\u30d3\u30ac\u30f3\uff08\u30d5\u30a1\u30d3\u30d4\u30e9\u30d3\u30eb\uff09\u3001\u304a\u3088\u3073\u56de\u5fa9\u671f\u8840\u6f3f\u304b\u30892\u3064\u3092\u4f75\u7528\u3059\u308b\u65b9\u6cd5\u3067\u3042\u308b\u3002"
      ]
    },
    {
      "AbstractText": [
        "\uc0c8\ub85c\uc6b4 \uc911\uc99d\uae09\uc131\ud638\ud761\uae30\uc99d\ud6c4\uad70 \ucf54\ub85c\ub098\ubc14\uc774\ub7ec\uc2a42(SARS-CoV-2)\uc758 \uac10\uc5fc\uc73c\ub85c \uc778\ud55c \ucf54\ub85c\ub098\ubc14\uc774\ub7ec\uc2a4\uac10\uc5fc\uc99d-19(COVID-19) \ubc1c\ubcd1\uc774 2019\ub144 12\uc6d4 \uc911\uad6d \uc6b0\ud55c\uc5d0\uc11c \ubc1c\uc0dd\ud558\uc600\ub2e4. \uc774 \uc0c8\ub85c\uc6b4 \ubc14\uc774\ub7ec\uc2a4\ub294 \uc678\ud53c\ubcf4\uc720 RNA \ubca0\ud0c0 \ucf54\ub85c\ub098\ubc14\uc774\ub7ec\uc2a4 \uad70\uc5d0 \uc18d\ud55c\ub2e4. \uac10\uc5fc\uc790\ub9c8\ub2e4 \uc99d\uc0c1\uc774 \uc0c1\uc774\ud560 \uc218 \uc788\uc73c\ub098, \uc8fc\uc694\ud55c \uc99d\uc0c1 \ubc1c\ud604\uc5d0\ub294 \ub9c8\ub978\uae30\uce68, \ucf54\ub9c9\ud798, \ud638\ud761\uace4\ub780, \ubc1c\uc5f4, \uc804\uc2e0\ubb34\ub825\uac10\uc774 \ud3ec\ud568\ub41c\ub2e4. \uc774 \uc9c8\ubcd1\uc740 60\uc138 \uc774\uc0c1\uc758 \ud658\uc790\uc640 \ub2f9\ub1e8, \uc554, \uc2ec\ud608\uad00 \uc9c8\ud658, \ub9cc\uc131 \ud638\ud761\uae30 \uc9c8\ud658, \uace0\ud608\uc555\uacfc \uac19\uc740 \uae30\uc800 \uc9c8\ud658\uc790\ub4e4\uc5d0\uc11c \ub354 \uc911\uc99d\uc73c\ub85c \ub098\ud0c0\ub09c\ub2e4. \uc2b9\uc778\ub41c COVID-19 \ubc31\uc2e0\uc740 \uc544\uc9c1 \uc5c6\uc73c\ub098, 100\uac1c \uc774\uc0c1\uc758 \ubc31\uc2e0\uc774 \uc11c\ub85c \ub2e4\ub978 \uac1c\ubc1c \ub2e8\uacc4\uc5d0 \uc788\ub2e4. \uc2e0\uc57d \uac1c\ubc1c\uc740 \uc0c1\ub300\uc801\uc73c\ub85c \uc624\ub79c \uc2dc\uac04\uc774 \uac78\ub9ac\ubbc0\ub85c, \uc774 \uc9c8\ubcd1\uc758 \uce58\ub8cc\ub97c \uc704\ud574 \uc774\ubbf8 \uc54c\ub824\uc9c0\uac70\ub098 \uc2b9\uc778\ub41c \uc5ec\ub7ec \uc57d\ubb3c\uc744 \uc7ac\ucc3d\ucd9c\ud558\uace0 \uc788\ub2e4. \uc774 \ub9ac\ubdf0\ub17c\ubb38\uc5d0\uc11c\ub294 COVID-19\uc758 \ubc1c\ubcd1 \uc774\ud6c4 6\uac1c\uc6d4 \ub3d9\uc548 \uc774\uc6a9 \uac00\ub2a5\ud55c \uce58\ub8cc\uc81c\uc640 \ubc31\uc2e0\uc758 \uc120\ud0dd\uc9c0\uc5d0 \ub300\ud574 \ud0d0\uad6c\ud55c\ub2e4. \uac00\uc7a5 \uc8fc\ubaa9\ud560 \ub9cc\ud55c \uce58\ub8cc\uc81c \uc635\uc158\uc740 \ub371\uc0ac\uba54\ud0c0\uc190, \ub818\ub370\uc2dc\ube44\ub974, \uc544\ube44\uac04(favipiravir), \ud68c\ubcf5\uae30\ud608\uc7a5\uc758 \uc774\uc911 \ubcd1\uc6a9\uc694\ubc95\uc774\ub2e4."
      ]
    },
    {
      "AbstractText": [
        "\u7531\u65b0\u578b\u4e25\u91cd\u6025\u6027\u547c\u5438\u7cfb\u7edf\u7efc\u5408\u75c7\u51a0\u72b6\u75c5\u6bd22\uff08SARS-CoV-2\uff09\u611f\u67d3\u5f15\u8d77\u76842019\u5e74\u51a0\u72b6\u75c5\u6bd2\u75c5\uff08COVID-19\uff09\u4e8e2019\u5e7412\u6708\u5728\u4e2d\u56fd\u6b66\u6c49\u7206\u53d1\u3002\u8fd9\u79cd\u65b0\u75c5\u6bd2\u5c5e\u4e8e\u5305\u819c\u03b2\u5c5e\u7684RNA\u51a0\u72b6\u75c5\u6bd2\u3002\u4e0d\u540c\u611f\u67d3\u8005\u7684\u75c7\u72b6\u53ef\u80fd\u6709\u6240\u4e0d\u540c\uff0c\u4f46\u5176\u4e3b\u8981\u75c7\u72b6\u5305\u62ec\u5e72\u54b3\u3001\u9f3b\u585e\u3001\u547c\u5438\u6025\u4fc3\u3001\u53d1\u70e7\u548c\u5168\u8eab\u4e0d\u9002\u3002\u8be5\u75be\u75c5\u4f3c\u4e4e\u572860\u5c81\u4ee5\u4e0a\u7684\u60a3\u8005\u4ee5\u53ca\u60a3\u6709\u8bf8\u5982\u7cd6\u5c3f\u75c5\u3001\u764c\u75c7\u3001\u5fc3\u8840\u7ba1\u75be\u75c5\u3001\u6162\u6027\u547c\u5438\u7cfb\u7edf\u75be\u75c5\u548c\u9ad8\u8840\u538b\u7b49\u6f5c\u5728\u75be\u75c5\u7684\u60a3\u8005\u4e2d\u66f4\u4e3a\u4e25\u91cd\u3002\u76ee\u524d\u5c1a\u65e0\u4efb\u4f55\u9488\u5bf9COVID-19\u7684\u75ab\u82d7\u88ab\u6279\u51c6\u4f7f\u7528\uff0c\u4f46\u4e5f\u6709\u4e00\u767e\u591a\u79cd\u75ab\u82d7\u6b63\u5904\u4e8e\u4e0d\u540c\u7684\u5f00\u53d1\u9636\u6bb5\u3002\u4f17\u6240\u5468\u77e5\uff0c\u65b0\u836f\u7684\u5f00\u53d1\u9700\u8981\u76f8\u5bf9\u8f83\u957f\u7684\u65f6\u95f4\uff0c\u56e0\u6b64\u51e0\u79cd\u5df2\u77e5\u4e14\u5df2\u88ab\u6279\u51c6\u4f7f\u7528\u7684\u836f\u7269\u88ab\u8f6c\u7528\u4e8e\u6cbb\u7597\u8be5\u75be\u75c5\u3002\u5728\u672c\u6587\u4e2d\uff0c\u6211\u4eec\u63a2\u8ba8\u4e86COVID-19\u7206\u53d16\u4e2a\u6708\u540e\u53ef\u88ab\u4f7f\u7528\u7684\u6cbb\u7597\u65b9\u6cd5\u548c\u75ab\u82d7\u3002\u5728\u5404\u79cd\u6cbb\u7597\u65b9\u6cd5\u4e2d\uff0c\u6700\u503c\u5f97\u4e00\u63d0\u7684\u662f\u4f7f\u7528\u5730\u585e\u7c73\u677e\u3001\u745e\u5fb7\u897f\u97e6\u3001\u6cd5\u5339\u62c9\u97e6\uff08favipiravir\uff09\u548c\u6062\u590d\u671f\u8840\u6d46\u3002"
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33319627",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/2472555220979579"
    ],
    "Journal": {
      "ISSN": "2472-5560",
      "JournalIssue": {
        "Volume": "26",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "SLAS discovery : advancing life sciences R & D",
      "ISOAbbreviation": "SLAS Discov"
    },
    "ArticleTitle": "Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak.",
    "Pagination": {
      "StartPage": "311",
      "EndPage": "329",
      "MedlinePgn": "311-329"
    },
    "Abstract": {
      "AbstractText": [
        "An outbreak of the coronavirus disease 2019 (COVID-19) caused by an infection of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, in December 2019. This new virus belongs to the group of enveloped RNA beta-coronaviruses. Symptoms may differ in various infected persons, but major presentations include dry cough, nasal congestion, shortness of breath, fever, and general malaise. The disease appears to be more severe in patients above the age of 60 years and those with underlying conditions such as diabetes, cancer, cardiovascular diseases, chronic respiratory disease, and hypertension. There is still no approved vaccine against COVID-19, but more than a hundred are at different stages of development. It is known that the development of new drugs takes a relatively long time, so several known and already-approved drugs are being repurposed for the treatment of this disease. In this review, we explore the therapeutic and vaccine options that are available for COVID-19 6 months after its outbreak. Most noteworthy among the therapeutic options are dexamethasone, remdesivir, Avigan (favipiravir) and convalescent plasma."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-4163-9535"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Loyola University Medical Center, Maywood, IL, USA."
          }
        ],
        "LastName": "Maciorowski",
        "ForeName": "Dawid",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Animal and Environmental Biology, Federal University Oye-Ekiti, Ekiti State, Nigeria."
          }
        ],
        "LastName": "Ogaugwu",
        "ForeName": "Christian",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Loyola University Medical Center, Maywood, IL, USA."
          }
        ],
        "LastName": "Durvasula",
        "ForeName": "Subba Rao",
        "Initials": "SR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Loyola University Medical Center, Maywood, IL, USA."
          }
        ],
        "LastName": "Durvasula",
        "ForeName": "Ravi",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Loyola University Medical Center, Maywood, IL, USA."
          }
        ],
        "LastName": "Kunamneni",
        "ForeName": "Adinarayana",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "SLAS Discov",
    "NlmUniqueID": "101697563",
    "ISSNLinking": "2472-5552"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Amides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyrazines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Proteins"
    },
    {
      "RegistryNumber": "3QKI37EEHE",
      "NameOfSubstance": "remdesivir"
    },
    {
      "RegistryNumber": "415SHH325A",
      "NameOfSubstance": "Adenosine Monophosphate"
    },
    {
      "RegistryNumber": "7S5I7G3JQL",
      "NameOfSubstance": "Dexamethasone"
    },
    {
      "RegistryNumber": "EW5GL2X7E0",
      "NameOfSubstance": "favipiravir"
    },
    {
      "RegistryNumber": "OF5P57N2ZX",
      "NameOfSubstance": "Alanine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Adenosine Monophosphate"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Alanine"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amides"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Dexamethasone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunization, Passive"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Pyrazines"
    },
    {
      "QualifierName": [
        "chemistry",
        "drug effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Viral Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Serotherapy"
    }
  ],
  "CoiStatement": "\n<b>Declaration of Conflicting Interests</b>\n. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
}